Clinical Trials Logo

Clinical Trial Summary

To review current Emergency Department procedural sedation practices in the community hospital setting and the associated drugs used (class of anesthetic and mode of administration). The ultimate goal of this investigation is to determine the need for a new analgesic/anesthesia drug and to compare the outcomes of a new drug within the same community Emergency Department setting. In particular, this may present a future opportunity to evaluate Penthrox (methoxyflurane) as a viable alternative for procedural sedation and analgesia in Canadian Emergency Departments.


Clinical Trial Description

Procedural sedation is a common practice in the Emergency Department setting. The purpose of procedural sedation is to provide adequate pain relief to patients undergoing an emergent procedure. As a result, the time to the patient's symptom relief, the degree of side effects and the duration of action of the medication are all critical to selecting an appropriate sedative and/or analgesic.

The community hospital setting may present unique challenges to successfully administering procedural sedation techniques. Funding and resource allocation can limit patient access to timely sedation/analgesia. This can be compounded by prolonged stays in the Emergency Department for recovery and/or complications.

The current recommendations for 'Procedural Sedation and Analgesia in the Emergency Department' outlines recommended medications and policies for adults and children undergoing procedural sedation1,2. While a number of cohort and retrospective analyses have been done in a variety of research settings, the role for oral or intranasal anesthesia has not been adequately explored in ED settings. The initial phase of this research proposal will identify current local practices through chart review analysis collected over the last year. Subsequent research questions might include a comparative analysis of the current procedural sedation techniques compared to medications administered orally or by inhalation. This may have considerable future benefit to patient satisfaction and clinical outcomes, as well as resource and operational outcomes in the Emergency Department.

Hypothesis

To identify interventions requiring procedural sedation and the medication commonly used in a Canadian community emergency department (ED). Using standardized medical record review methods, primary clinical patient indicators, safety outcomes and secondary ED operational outcomes will be reviewed.3

Study Design

This retrospective chart review will be obtained from data of patients who have registered in the Welland County General Hospital (WHS) from the dates of January 2017 -December 2018. This timeframe should capture a sample size of ~300 patients.

Patients will be included in our study if they have received conscious sedation for a diagnostic or therapeutic procedure in the emergency department. They will be identified through review of billing records for anesthesia codes. Medical records, specifically physician procedural sedation records and nursing documentation, will be our main resources for data extraction. The investigators will describe and quantify the procedures requiring conscious sedation and identify the medication (and route) used, using a standardized data abstraction tool to be created from international ED PSA guidelines.1,2 Primary outcome measures will include ED PSA indications, pre-procedural assessments (medical comorbidities, difficult airway predictors, other safety factors), medications used, sedation failures/use of rescue medications, procedural successes or failures, post-PSA assessments, PSA recovery and patient disposition. Further stratification by age and other demographic features will help us better understand trends between the adult and pediatric population.

Patients requiring anaesthesia for the purpose of intubation and ventilator support will be excluded from this study.

Our secondary outcomes involve resource utilization and complications. Duration of procedure and time to discharge will be measured. Data on adverse outcomes and unplanned admission rates will also be collected. Adverse outcomes of interest will be vomiting, medication for blood pressure support, dysrhythmias, unanticipated intubation, laryngospasm, pulse oximetry less than 90%, apnea requiring bag-valve-mask ventilation and death. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04172415
Study type Observational
Source Niagara Health System
Contact
Status Enrolling by invitation
Phase
Start date November 30, 2019
Completion date October 1, 2020

See also
  Status Clinical Trial Phase
Terminated NCT02573818 - Sedasys Post Approval Study Users Response to System Alarms N/A
Recruiting NCT01100554 - Upper Airway Collapsibility Evaluation in Different Sedative Levels by Sleep Endoscopy N/A
Terminated NCT00226785 - Dexmedetomidine for Continuous Sedation Phase 3
Completed NCT02518919 - Procedural Sedation And Analgesia in Children in the Emergency Department: The Role of Adjunct Therapies N/A
Completed NCT01020643 - Closed-loop Sedation of Propofol for Patients Undergoing Spinal Anesthesia Phase 4
Completed NCT00318955 - Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients Phase 4
Completed NCT04621526 - Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma Phase 1/Phase 2
Completed NCT03085563 - A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department Phase 4
Completed NCT01873612 - Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers Phase 4
Not yet recruiting NCT03466242 - IN Dexmedetomidine for Procedural Sedation in Pediatric Closed Reductions for Distal Forearm Fractures Early Phase 1
Completed NCT02679781 - Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care N/A
Completed NCT03885427 - Analgo-Sedative Effects Of Oral, Or Nebulized Ketamine In Pre-schoolers Undergoing Elective Surgery. Early Phase 1
Completed NCT00452426 - Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy Phase 3
Completed NCT00261599 - An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy Phase 3
Completed NCT00641563 - Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Electroencephalogram (EEG) N/A
Active, not recruiting NCT01118884 - Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide for Uncooperative Children Phase 3
Terminated NCT00809380 - Parental Presence During Fracture Reduction in Children at the Emergency Department; A Randomized Controlled Trial N/A
Completed NCT03886454 - Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study
Completed NCT03925779 - Conscious Sedation for Outpatient Colonoscopy Phase 2
Completed NCT06181188 - Use of Ketamine for Conscious Sedation in Flexible Bronchoscopy Phase 4